secwatch.observer — SEC 8-K summary
======================================

Issuer:     VITASPRING BIOMEDICAL CO. LTD. (VSBC)
CIK:        0001697884
Form:       8-K
Filed at:   2021-08-11T23:59:59+00:00
Accession:  0001697884-21-000011
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CEO Chu Pao-Chi resigns; Kao Cheng-Hsiang appointed CEO and retains Secretary role
--------------------------------------------------------------------------------

- Chu Pao-Chi resigned as CEO effective August 7, 2020.
- Kao Cheng-Hsiang, former secretary, appointed CEO and retains secretary position.
- Chief Technical Officer Lin Jer-Li and Technical Vice-President Chen Yen Xun remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1697884/000169788421000011/0001697884-21-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1697884/000169788421000011/8kceochange.htm
  HTML page:      https://secwatch.observer/filing/0001697884-21-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer